Average Co-Inventor Count = 5.46
ph-index = 22
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (57 from 1,147 patents)
2. Astrazeneca Ab (7 from 1,494 patents)
3. Msd K.k. (3 from 47 patents)
4. Astra Zeneca U.k. Limited (2 from 105 patents)
5. Other (1 from 832,398 patents)
6. Merck Patent Gmbh (1 from 2,929 patents)
67 patents:
1. 10988477 - GCN2 inhibitors and uses thereof
2. 10961232 - Substituted pyrazines as ATR kinase inhibitors
3. 10479784 - Substituted pyrazin-2-amines as inhibitors of ATR kinase
4. 9701674 - Substituted pyrazines as ATR kinase inhibitors
5. 9365557 - Substituted pyrazin-2-amines as inhibitors of ATR kinase
6. 9309250 - Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors
7. 9096602 - Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors
8. 8987454 - Azaindoles useful as inhibitors of JAK and other protein kinases
9. 8962642 - 5-cyano-4- (pyrrolo [2,3B] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
10. 8822469 - Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase
11. 8785444 - Thiazoles and pyrazoles useful as kinase inhibitors
12. 8741931 - Kinase inhibitors
13. 8722889 - Azaindoles useful as inhibitors of JAK and other protein kinases
14. 8637511 - Aminopyrimidines useful as kinase inhibitors
15. 8557833 - Aminopyrimidines useful as kinase inhibitors